e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function decline in COPD trials: bias from regression to the mean
Suissa S.
Source:
Eur Respir J 2008; 32: 829-831
Journal Issue:
October
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Suissa S.. Lung function decline in COPD trials: bias from regression to the mean. Eur Respir J 2008; 32: 829-831
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Lung function decline in COPD trials
Source: Eur Respir J 2009; 33: 708-709
Year: 2009
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Estimating lung function decline and the effect of smoking in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 578s
Year: 2002
Hierarchical linear models for longitudinal change in COPD - is there an effect of differential dropout between treatment groups on estimated decline rates?
Source: Eur Respir J 2001; 18: Suppl. 33, 151s
Year: 2001
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Airway responsiveness predicts lung function decline differently in subjects with or without asthma: An international study
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Comparison of regression models for developing spirometric reference values
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Lung function decline in asthma
Source: Eur Respir J 2007; 30: 411-413
Year: 2007
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Predictors of lung function decline: a retrospective study in COPD patients
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Annual rate of FVC decline in patients with IPF treated with pirfenidone: Pooled analysis from 3 pivotal studies
Source: International Congress 2016 – IPF treatment I
Year: 2016
FEV
6
: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast
Source: Eur Respir J 2004; 24: Suppl. 48, 342s
Year: 2004
Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Predicting IPF outcomes: lung function evaluation by %predicted and z-score
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept